Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It...
26 insider purchases on record · latest filing 2025-12-17.
Insiders have also filed 80 sale transactions at DTIL.